Unique ID issued by UMIN | UMIN000028973 |
---|---|
Receipt number | R000032674 |
Scientific Title | A randomized double-blind placebo controlled trial on the effect of magnesium oxide in patients with chronic constipation |
Date of disclosure of the study information | 2017/09/15 |
Last modified on | 2019/03/18 22:38:06 |
A randomized double-blind placebo controlled trial on the effect of magnesium oxide in patients with chronic constipation
Effect of magnesium oxide in patients with chronic constipation
A randomized double-blind placebo controlled trial on the effect of magnesium oxide in patients with chronic constipation
Effect of magnesium oxide in patients with chronic constipation
Japan |
Chronic constipation diadnosed by Rome IV criteria
Gastroenterology |
Others
NO
To assess the efficacy and colonic transit time with the use of magnesium oxide on chronic constipation
Efficacy
overall treatment efficacy
1.Monthly responder rates and weekly change from baseline in complete spontaneous bowel movement
2.Monthly responder rates and weekly change from baseline in spontaneous bowel movement
3.colon transit time
4.Bristol stool form
5.The patient assessment of constipation quality of life (JPAC-QOL) and SF-8
6.Weekly change from baselaine in symptom score of bloating
7.Weekly change from baselaine in symptom score of abdominal discomfort
8.Weekly change from baselaine in symptom score of afeeling of remaining faces
9.Weekly change from baselaine in symptom score of severity of straining
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Treatment
Medicine |
magnesium oxide
placebo
20 | years-old | <= |
75 | years-old | > |
Male and Female
Chronic constipation patient aged 20-74 years and diagnosed according to the RomeIV criteria
Candidates are excluded if they prescribe drug for constipation in hospital or use the over the counter medicines for constipation Everyday
Candidates are excluded if they cannot use the over the counter medicines for constipation until fourteen days from consent of this study
Candidates are excluded if any of the following are evident:
current evidence of renal dysfuncti or cardiac disturbance or hypermagnesemia
Secondary constipation candidates are excluded
Candidates are excluded if take a madecine of the proton pump inhibitor or the potassium-competitive acid blocher
Female patient could not be pregnant,as confirmed by a negative serum pregnancy test at the baseline visit
34
1st name | Toshihiko |
Middle name | |
Last name | Tomita |
Hypgo College of Medicine
Division of Gastroenterology,Department of Internal Medicine
663-8501
Nishinomiya
0798456661
tomita@hyo-med.ac.jp
1st name | Toshihiko |
Middle name | |
Last name | Tomita |
Dr.
Division of Gastroenterology,Department of Internal Medicine
6638501
Nishinomiya
0798456661
tomita@hyo-med.ac.jp
Hyogo College of Medicine
Hyogo College of Medicine
Self funding
Hyogo College of Medicine
1-1, Mukogawa-chou, Nishinomiya
0798456661
tomita@hyo-med.ac.jp
NO
2017 | Year | 09 | Month | 15 | Day |
Unpublished
Preinitiation
2017 | Year | 08 | Month | 21 | Day |
2017 | Year | 09 | Month | 15 | Day |
2019 | Year | 03 | Month | 18 | Day |
2019 | Year | 03 | Month | 18 | Day |
2017 | Year | 09 | Month | 02 | Day |
2019 | Year | 03 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032674
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |